ArticleIrish journal of medical science2025
Evaluating diabetic retinopathy service utilisation amongst Cardiology Department admissions.
Article in Irish journal of medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDiabetic retinopathy (DR) is a major cause of preventable vision loss. Given the strong link between diabetes and cardiovascular disease [1], assessing DR screening uptake in cardiology inpatients offers insight into a high-risk group. DR screening services have been available in Ireland since 2013, facilitating early detection and vision preservation.
aimTo evaluate the utilisation rate of DR screening (DRS) service engagement among cardiology inpatients with a documented history of diabetes.
methodsRetrospective analysis of all patients with diabetes mellitus (DM) admitted under cardiology at our institution over a 12-month period. Patients were identified via medical chart review and invited to complete a standardised questionnaire. Patient demographics, reason for admission, type and duration of DM and Hba1c HbA1c were recorded. We then assessed whether these patients had previously engaged with DRS services.
resultsOne hundred forty patients with DM admitted under cardiology were identified. Of those, 69.3% (n = 97) were included. Patient demographics revealed: males (66%), females (33%) and mean age of 71.3 years (range 43-90]. The mean duration of diabetes was 14.24 years (range 2 months-66 years). Patients (94.985%) had Type2DM, and the mean HbA1c value was 58.7 (range 35-122). Patients (82.547%) (n = 80) were found to be linked in with DRS. Of those linked in with DRS, 17.5% (n = 14) had required treatment for eye disease.
conclusionThe percentage of our patients enrolled in DRS currently meets the Diabetic RetinaScreen target of 80% set by the Health Service Executive. This could be further enhanced by highlighting non-enrolment on discharge letters to general practitioners with a view to increasing DRS participation. This would provide an opportunity to increase participation and raise awareness of the screening program in the acute care setting.
Indexed as
Identifiers
40699285What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.